Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Boehringer Ingelheim study highlights atrial fibrillation education issues

Boehringer Ingelheim study highlights atrial fibrillation education issues

23rd March 2011

Boehringer Ingelheim has highlighted a new study which underlines the importance of improving awareness of atrial fibrillation (AF) and its impact on overall health.

The pharmaceutical company has sponsored the Speak about AF Survey, a large-scale international poll of patients and physicians treating the condition, which reveals that many sufferers are uninformed about the link between AF and strokes.

It was found that 51 percent of patients with AF are not concerned about an increased risk of strokes, despite the fact that 93 percent of physicians suggest that it is the most serious threat facing those in this group.

As a result, a global awareness campaign called 1 Mission 1 Million is being launched that will offer grants to projects that can increase understanding of the disease and reduce rates of AF-related strokes.

Eve Knight of UK-based AntiCoagulation Europe said: "The Speak about AF Survey showed that the more information people with AF receive, the less worried they feel about their condition, therefore lessening the emotional burden of AF and improving quality of life."

Boehringer Ingelheim will be helping to sponsor the 1 Mission 1 Million campaign, which this week recruited actress Jane Seymour as an ambassador and spokesperson.ADNFCR-8000103-ID-800472823-ADNFCR

We currently have 9 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.